BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 6298448)

  • 1. Application of denatured, electrophoretically separated, and immobilized lysates of herpes simplex virus-infected cells for detection of monoclonal antibodies and for studies of the properties of viral proteins.
    Braun DK; Pereira L; Norrild B; Roizman B
    J Virol; 1983 Apr; 46(1):103-12. PubMed ID: 6298448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart.
    Roizman B; Norrild B; Chan C; Pereira L
    Virology; 1984 Feb; 133(1):242-7. PubMed ID: 6199891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus glycoprotein gA/B: evidence that the infected Vero cell products comap and arise by proteolysis.
    Pereira L; Dondero D; Roizman B
    J Virol; 1982 Oct; 44(1):88-97. PubMed ID: 6292507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological reactivity of herpes simplex virus 1 and 2 polypeptides electrophoretically separated and transferred to diazobenzyloxymethyl paper.
    Norrild B; Pedersen B; Roizman B
    Infect Immun; 1981 Feb; 31(2):660-7. PubMed ID: 6260673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification, properties, and gene location of a novel glycoprotein specified by herpes simplex virus 1.
    Ackermann M; Longnecker R; Roizman B; Pereira L
    Virology; 1986 Apr; 150(1):207-20. PubMed ID: 3006335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections.
    Eberle R; Mou SW; Zaia JA
    J Med Virol; 1985 Jun; 16(2):147-62. PubMed ID: 2409225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of monoclonal antibodies to HSV-1 and HSV-2 for serological analysis of the viral glycoproteins.
    Pereira L
    Dev Biol Stand; 1982; 52():115-31. PubMed ID: 6299824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential immunologic reactivity and processing of glycoproteins gA and gB of herpes simplex virus types 1 and 2 made in Vero and HEp-2 cells.
    Pereira L; Dondero D; Norrild B; Roizman B
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5202-6. PubMed ID: 6272294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection in antisera of antibodies that cross-react with herpes simplex virus type 1 glycoprotein gC.
    Zweig M; Heilman CJ; Bladen SV; Showalter SD; Hampar B
    Infect Immun; 1983 Aug; 41(2):482-7. PubMed ID: 6307870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
    Glorioso J; Szczesiul MS; Marlin SD; Levine M
    Virology; 1983 Apr; 126(1):1-18. PubMed ID: 6189286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoblotting and ELISA analysis of HSV-1 and HSV-2-specified polypeptides by using an immunoblocking method.
    Lehtinen M
    Ann Clin Res; 1985; 17(2):66-70. PubMed ID: 2412480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of herpes simplex virus type 1 glycoproteins: two-dimensional gel analysis using monoclonal antibodies.
    Palfreyman JW; Haarr L; Cross A; Hope RG; Marsden HS
    J Gen Virol; 1983 Apr; 64 (Pt 4)():873-86. PubMed ID: 6300307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to a synthetic oligopeptide that react with herpes simplex virus type 1 and 2 glycoprotein C.
    Zweig M; Showalter SD; Simms DJ; Hampar B
    J Virol; 1984 Aug; 51(2):430-6. PubMed ID: 6086954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the HSV-2 early AG-4 antigen.
    Evans LA; Sheppard M; May JT
    Arch Virol; 1985; 85(1-2):13-23. PubMed ID: 2990385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential detection of different antigens induced by Epstein-Barr virus and herpes simplex virus in the same Western blot by using dual antibody probes.
    Lin JC; Pagano JS
    J Virol; 1986 Aug; 59(2):522-4. PubMed ID: 3016315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of post-translational products of herpes simplex virus gene 35 proteins binding to the surfaces of full capsids but not empty capsids.
    Braun DK; Roizman B; Pereira L
    J Virol; 1984 Jan; 49(1):142-53. PubMed ID: 6317887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Typing of herpes simplex virus types 1 and 2 by immunoblotting analysis using polyclonal antisera to herpes simplex virus glycoproteins.
    Okazaki K; Chiya S; Ideguchi S; Kimura S
    J Virol Methods; 1987 Nov; 18(2-3):169-78. PubMed ID: 2828400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of herpes simplex virus 1 alpha proteins 0, 4, and 27 with monoclonal antibodies.
    Ackermann M; Braun DK; Pereira L; Roizman B
    J Virol; 1984 Oct; 52(1):108-18. PubMed ID: 6090689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.